Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

JDRF Canada welcomes Bill C-399, an Act to Amend the Income Tax Act (Disability Tax Credit)

Ottawa, March 21, 2018 – JDRF Canada welcomes Bill C-399, an Act to Amend the Income Tax Act (Disability Tax Credit), as a positive step towards addressing some of the longer-term problems faced by Canadians with type 1 diabetes in qualifying for the Disability Tax Credit. The bill, sponsored by Tom Kmiec, MP for Calgary Shepard, was introduced today in the House of Commons.

“Bill C-399 will make it easier for more Canadians with diabetes and others to qualify for the Disability Tax Credit by making some small but meaningful changes to the Income Tax Act. Importantly, it recognizes the arbitrary nature of the 14-hour requirement for life-sustaining therapy. By reducing the number of hours to 10, we’ll see more people who are in need of this support qualify,” says Dave Prowten, president and CEO of JDRF Canada. “The bill will also allow for carbohydrate calculation to be included as part of time spent managing diabetes, which is just common sense as it is impossible to calculate appropriate insulin dosages without taking into account carbohydrates.” 

JDRF is the leading global organization funding type 1 diabetes research. JDRF’s goal is to progressively remove the impact of type 1 diabetes from people’s lives until we achieve a world without this disease. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure type 1 diabetes.

Media contact

Lolita Osorio
National Director, Marketing and Communications
JDRF Canada
losorio@jdrf.ca
647.465.5694

Sign up for our newsletter and stay connected

Donate | Donnez